Quote Originally Posted by Silverlight View Post
The story for Rakon is they did what Pumpkin Patch did (i.e David Jackson). They assumed they were the 'experts' and just read the experts advise, and then did whatever they wanted about the currency.

Fisher and Paykel Healthcare however (i.e Tony Carter and their risk committee) understand that they pay experts for their experts advise and follow what the currency experts say.

I have read many Asia Pacific currency reports, and they are frequent and pretty spot on. David Jackson and Bruce Irvine both believed they knew better and failed. Pumpkin Patch is better off without David Jackson on their board and running their risk committee.

Asia Pacific client list

Overall good forecast, shows the Medicare process was a good buying opportunity, $3+ by year end, especially if we also get some currency relief.

I have halved my holding, while some analysts have now forecast a high target price (nearly $5), this stock has had a very good run, and reflects no downside risk for the currency. Was great buying @ $2.50, now its looking pretty expensive above $4. Trading on almost a 30 P/E.